Gene engineering biological therapy for juvenile arthritis

The mechanisms of action of currently used genetic engineering biological agents (GEBAs) include inhibition of cytokines, interleukins, and T cells and depletion of B cells. GEBAs were originally accessible mainly for the treatment of refractory juvenile idiopathic arthritis (JIA), including systemi...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Kh Mikhel's, Irina Petrovna Nikishina, E S Fedorov, S O Salugina, H Michels
Format: Artigo
Jezik:Russo
Izdano: IMA-PRESS LLC 2011-02-01
Serija:Научно-практическая ревматология
Teme:
genetic engineering biological agents in children
juvenile arthritis
biological therapy for juvenile arthritis
Online dostop:https://rsp.mediar-press.net/rsp/article/view/1006
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki